These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 23722017)
21. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall. Gordetsky J; Epstein JI Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758 [TBL] [Abstract][Full Text] [Related]
22. T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival. Yang M; Yu Q; Liu J; Fu W; Cao Y; Yu L; Shao S; Wang X; Niu H; Wang Y J Surg Oncol; 2015 Sep; 112(4):430-5. PubMed ID: 26265374 [TBL] [Abstract][Full Text] [Related]
23. [Expression of Caspase-3 and Bcl-2 in bladder transitional carcinoma and their significance]. Shen HW; Yi L; Wang XM; Yao MJ; Deng JW; Fang JZ; Li MN Ai Zheng; 2004 Feb; 23(2):181-4. PubMed ID: 14960240 [TBL] [Abstract][Full Text] [Related]
24. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma. Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066 [TBL] [Abstract][Full Text] [Related]
26. High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder. Li W; Liu M; Feng Y; Huang YF; Xu YF; Che JP; Wang GC; Zheng JH Int J Clin Exp Pathol; 2013; 6(11):2430-40. PubMed ID: 24228105 [TBL] [Abstract][Full Text] [Related]
27. ARID1A alteration in aggressive urothelial carcinoma and variants of urothelial carcinoma. Li J; Lu S; Lombardo K; Monahan R; Amin A Hum Pathol; 2016 Sep; 55():17-23. PubMed ID: 27137986 [TBL] [Abstract][Full Text] [Related]
28. Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder. Yin W; Chen N; Zhang Y; Zeng H; Chen X; He Y; Wang X; Zhou Q Mod Pathol; 2006 Nov; 19(11):1487-97. PubMed ID: 16892011 [TBL] [Abstract][Full Text] [Related]
29. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder. Bi J; Chen X; Zhang Y; Li B; Sun J; Shen H; Kong C Urol Oncol; 2012 Sep; 30(5):688-94. PubMed ID: 20888270 [TBL] [Abstract][Full Text] [Related]
30. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis. Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762 [TBL] [Abstract][Full Text] [Related]
31. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker. Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Kawaoka K; Wong SG; Belldegrun AS; Pantuck AJ Cancer; 2009 Apr; 115(7):1448-58. PubMed ID: 19195047 [TBL] [Abstract][Full Text] [Related]
32. Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer. Kim K; Cho YM; Park BH; Lee JL; Ro JY; Go H; Shim JW Int J Clin Exp Pathol; 2015; 8(1):743-50. PubMed ID: 25755769 [TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas. Donmez G; Sullu Y; Baris S; Yildiz L; Aydin O; Karagoz F; Kandemir B Pathol Res Pract; 2009; 205(12):854-7. PubMed ID: 19762163 [TBL] [Abstract][Full Text] [Related]
34. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection. Chang WC; Chang YH; Pan CC Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706 [TBL] [Abstract][Full Text] [Related]
35. Overexpression and clinicopathological contribution of DcR3 in bladder urothelial carcinoma tissues. Jiang YQ; Zhong TF; Dang YW; Zou LS; Yang L; Yang X; Chen G Asian Pac J Cancer Prev; 2014; 15(21):9137-42. PubMed ID: 25422191 [TBL] [Abstract][Full Text] [Related]
36. Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours? Plastiras D; Moutzouris G; Barbatis C; Presvelos V; Petrakos M; Theodorou C Eur J Surg Oncol; 1999 Feb; 25(1):61-5. PubMed ID: 10188857 [TBL] [Abstract][Full Text] [Related]
37. Lower mRNA and protein expression levels of LC3 and Beclin1, markers of autophagy, were correlated with progression of renal clear cell carcinoma. Deng Q; Wang Z; Wang L; Zhang L; Xiang X; Wang Z; Chong T Jpn J Clin Oncol; 2013 Dec; 43(12):1261-8. PubMed ID: 24186908 [TBL] [Abstract][Full Text] [Related]
38. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder. Zhang Z; Zhang G; Kong C Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978 [TBL] [Abstract][Full Text] [Related]
39. βIII-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancer. Hinsch A; Chaker A; Burdelski C; Koop C; Tsourlakis MC; Steurer S; Rink M; Eichenauer TS; Wilczak W; Wittmer C; Fisch M; Simon R; Sauter G; Büschek F; Clauditz T; Minner S; Jacobsen F Hum Pathol; 2017 Mar; 61():210-220. PubMed ID: 28025079 [TBL] [Abstract][Full Text] [Related]
40. Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder. Reis LO; Taheri D; Chaux A; Guner G; Mendoza Rodriguez MA; Bivalacqua TJ; Schoenberg MP; Epstein JI; Netto GJ Hum Pathol; 2016 Jan; 47(1):20-5. PubMed ID: 26520419 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]